Gary E. Swan, Ph.D., is the director of the Center for Health Sciences at SRI International. In this role, he works with researchers in the areas of neuroscience, molecular genetics, addiction, human sleep, and behavioral pharmacology.
Swan's research interests include treatment of nicotine dependence, genetic and environmental determinants of addiction and disease, brain aging, and pharmacogenetics. He directs SRI’s Twin Research Registry™, overseeing research and volunteer recruitment for an active registry of twins of all ages and backgrounds. He has been principal investigator or co-investigator on more than 20 NIH-funded grants and has published more than 190 manuscripts in peer-reviewed journals.
In addition to his role at SRI, Swan reviews grants for a number of institutes at the NIH, reviews manuscripts for more than 20 peer-reviewed journals, and is a member of the American Psychological Association, Society of Behavioral Medicine (Fellow, 1993), Gerontological Society of America, and the Society for Research on Nicotine and Tobacco. Swan previously served as editor-in-chief of Nicotine & Tobacco Research.
At SRI, Swan has twice received Professional Excellence awards in addition to the Fellowship Award, SRI's highest honor for researchers. Swan received his doctorate in psychology from the State University of New York at Stony Brook.
Swan was named an SRI Fellow in 1997.